|
|
|
|
|||||
|
|
|
Tilray Brands Inc. (NASDAQ:TLRY) is one of the best penny stocks under $1 to buy now. On June 26, Tilray Brands, through its medical division, Tilray Medical, published a new scientific study on the bioavailability of different cannabinoid formulations.
This research, conducted on healthy volunteers, compared Tilray’s oral THC:CBD extract with oromucosally administered nabiximols.
The findings show that Tilray’s oral extract resulted in higher and faster concentrations of THC and CBD in the bloodstream.
Tilray Brands Inc. (NASDAQ:TLRY) is a lifestyle consumer products company that researches, cultivates, processes, and distributes medical cannabis products in Canada, the US, Europe, Australia, New Zealand, Latin America, and internationally.
While we acknowledge the potential of TLRY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
| Jul-25 | |
| Jul-25 | |
| Jul-24 | |
| Jul-23 | |
| Jul-23 | |
| Jul-23 | |
| Jul-22 | |
| Jul-22 | |
| Jul-21 | |
| Jul-19 | |
| Jul-18 | |
| Jul-17 | |
| Jul-17 | |
| Jul-16 | |
| Jul-15 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite